A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 192 600 KRW 0.21% Market Closed
Market Cap: 10.6T KRW

Net Margin
ABL Bio Inc

-32.4%
Current
-81%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-32.4%
=
Net Income
-28.6B
/
Revenue
88.4B

Net Margin Across Competitors

Country Company Market Cap Net
Margin
KR
ABL Bio Inc
KOSDAQ:298380
10.6T KRW
-32%
IL
Can Fite Biopharma Ltd
TASE:CANF
168.5T ILS
-1 456%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-21 040%
US
Abbvie Inc
NYSE:ABBV
389.8B USD
4%
US
Amgen Inc
NASDAQ:AMGN
175.3B USD
19%
US
Gilead Sciences Inc
NASDAQ:GILD
153.6B USD
28%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113B USD
31%
US
Epizyme Inc
F:EPE
94.1B EUR
-392%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.2B USD
32%
AU
CSL Ltd
ASX:CSL
84.9B AUD
19%
NL
argenx SE
XBRU:ARGX
42.6B EUR
43%
No Stocks Found

ABL Bio Inc
Glance View

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

Intrinsic Value
14 708.98 KRW
Overvaluation 92%
Intrinsic Value
Price
A
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-32.4%
=
Net Income
-28.6B
/
Revenue
88.4B
What is the Net Margin of ABL Bio Inc?

Based on ABL Bio Inc's most recent financial statements, the company has Net Margin of -32.4%.

Back to Top